Evolus Inc. (EOLS) Stock Rises on Q4 2025 Earnings

Evolus Inc. ($EOLS) reported fourth-quarter 2025 results. Revenue rose 14.4% year‑over‑year to $90.3 million, slightly below the consensus estimate of $91.5 million. Gross profit increased 12.7% to $59.3 million.

Key income-statement highlights:

Revenue: $90.3 million (+14.4% YoY; estimate $91.5 million)

Gross profit: $59.3 million (+12.7% YoY)

Cost of sales: $31.0 million (+17.9% YoY)

Operating profit: $4.22 million (-282.4% YoY)

Net income attributable to common shareholders: $130,000 (-101.9% YoY)

Balance-sheet and cash-flow highlights:

Cash from operating activities: $12.83 million (+166.8% YoY)

Capital spending (purchases of property, plant and equipment): $955,000 (up 118.0% YoY)

Cash and cash equivalents: $53.8 million (-38.1% YoY)

Total liabilities: $249.0 million (+9.7% YoY)

Other items of note:

Diluted EPS: $0.00 (declined 100.0% YoY; consensus ~ $0.05)

Shares moved +9.96% since market close.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Evolus Inc. Insider Trading Activity

Evolus Inc. insiders have traded $EOLS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $EOLS stock by insiders over the last 6 months:

DAVID MOATAZEDI (See Remarks) sold 10,539 shares for an estimated $75,361
RUI AVELAR (See Remarks) sold 2,261 shares for an estimated $16,167

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Evolus Inc. Hedge Fund Activity

We have seen 94 institutional investors add shares of Evolus Inc. stock to their portfolio, and 106 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

TANG CAPITAL MANAGEMENT LLC removed 4,242,607 shares (-77.3%) from their portfolio in Q4 2025, for an estimated $28,213,336
CALIGAN PARTNERS LP removed 4,138,943 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $27,523,970
BRAIDWELL LP added 3,105,209 shares (+inf%) to their portfolio in Q4 2025, for an estimated $20,649,639
PERCEPTIVE ADVISORS LLC removed 2,474,843 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $15,195,536
TRI LOCUM PARTNERS LP removed 1,239,031 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,607,650
EVERSEPT PARTNERS, LP removed 1,131,005 shares (-76.7%) from their portfolio in Q4 2025, for an estimated $7,521,183
NUVEEN, LLC removed 982,998 shares (-91.8%) from their portfolio in Q4 2025, for an estimated $6,536,936

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Evolus Inc. Analyst Ratings

Wall Street analysts have issued reports on $EOLS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 02/03/2026
BTIG issued a "Buy" rating on 01/22/2026
Mizuho issued a "Outperform" rating on 12/02/2025

To track analyst ratings and price targets for Evolus Inc., check out Quiver Quantitative's $EOLS forecast page.

Evolus Inc. Price Targets

Multiple analysts have issued price targets for $EOLS recently. We have seen 4 analysts offer price targets for $EOLS in the last 6 months, with a median target of $15.0.

Here are some recent targets:

Douglas Tsao from HC Wainwright & Co. set a target price of $13.0 on 02/03/2026
Sam Eiber from BTIG set a target price of $13.0 on 01/22/2026
Annabel Samimy from Stifel set a target price of $17.0 on 01/13/2026
Uy Ear from Mizuho set a target price of $19.0 on 12/02/2025